SLC35A1 and neoplasm: Neutrophil ADCC was evaluated after pre-incubation of tumor cells with P3-FAX (efficacy of the treatment was verified prior to each ADCC, as depicted in Supplemental Figure S2c,e), or alternatively after use of the SLC35A1 KO cells.